Has anyone here audited a contract where IMC-EagleRx served as the downstream rebate administrator? I am particularly interested in how their performance guarantees held up against the major PBMs during the 2023-2024 drug shortage cycles.
This post is written from the perspective of a financial or pharma industry professional, as IMC-EagleRx is typically associated with pharmaceutical rebate contracting and financial management services. Navigating the PBM Landscape: A Look at IMC-EagleRx’s Role in Specialty Pharmacy Economics imc-eaglerx
For those unfamiliar, IMC-EagleRx operates as a specialized financial intermediary—often described as a "rebate management and administrative services" entity. They typically work with health plans, employers, and PBMs to streamline the flow of manufacturer rebates and fees. Has anyone here audited a contract where IMC-EagleRx
Disclaimer: This is for informational discussion only. Always verify contracting structures with your legal and financial advisors. Navigating the PBM Landscape: A Look at IMC-EagleRx’s